MBP and myeloid sarcoma: Notably, Streeter et al. [181] developed a new peptide-based therapy for MS, consisting of a mixture of different T cell epitopes derived from MBP that ameliorated the disease when applied prophylactically and also therapeutically to Obx-DR2 mice.